Skip to main content
. Author manuscript; available in PMC: 2011 Jun 15.
Published in final edited form as: Clin Infect Dis. 2010 Jun 15;50(12):1664–1671. doi: 10.1086/652867

Table 1.

Characteristics of study population (n=582) at the time of HAART eligibility, ALIVE cohort, 1996–2007*

Characteristic N (%)
Median age (interquartile range) 41 (36–45)
African-American Race 565 (97%)
Female gender 147 (25%)
≥ High school education 224 (39%)
Annual income <$5000 442 (79%)
Employed 110 (19%)
Recent homelessness 97 (17%)
Recent incarceration 113 (20%)
Alcohol use
    None 221 (39%)
    < daily 273 (48%)
    ≥daily 78 (14%)
Injection drug use
    None 230 (40%)
    < daily 151 (27%)
     ≥ daily 188 (33%)
Type of drug injected
    None 232 (40%)
    Cocaine alone 27 (5%)
    Heroin alone 31 (5%)
    Cocaine and Heroin 279 (49%)
Any non-injection drug use 234 (41%)
Any cocaine use 345 (60%)
Any crack use 123 (21%)
Methadone maintenance 73 (13%)
Median CD4 at eligibility 235 (140 – 297)
Median log10HIV RNA at eligibility 4.42 (3.81 – 4.82)
Prior AIDS diagnosis 49 (8%)
Prior antiretroviral therapy 359 (62%)
Usual source of care 397 (69%)
Recent outpatient visit 302 (53%)
Health insurance 378 (66%)
Calendar period of 1st eligibility
1996 – 1998 487 (84%)
1999 – 2002 63 (11%)
2003 – 2007 32 (5%)
*

Characteristics are presented as n(%) except where otherwise specified

Reflect characteristics/behaviors in the prior six months